Intensive Tuberculosis Screening for HIV‐Infected Patients Starting Antiretroviral Therapy in Durban, South Africa | Zendy

Ingrid V. Bassett | Zendy; Bingxia Wang | Zendy; Senica Chetty | Zendy; Janet Giddy | Zendy; Elena Losina | Zendy; Matilda Mazibuko | Zendy; Benjamin Bearnot | Zendy; Jenny Allen | Zendy; Rochelle P. Walensky | Zendy; Kenneth A. Freedberg | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Intensive Tuberculosis Screening for HIV‐Infected Patients Starting Antiretroviral Therapy in Durban, South Africa

Author(s) -

Ingrid V. Bassett,

Bingxia Wang,

Senica Chetty,

Janet Giddy,

Elena Losina,

Matilda Mazibuko,

Benjamin Bearnot,

Jenny Allen,

Rochelle P. Walensky,

Kenneth A. Freedberg

Publication year - 2010

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/656282

Subject(s) - medicine , tuberculosis , sputum , sputum culture , mycobacterium tuberculosis , confidence interval , chest radiograph , pathology , lung

The World Health Organization (WHO) recommends cough as the trigger for tuberculosis screening in human immunodeficiency virus (HIV)-infected patients, with acid-fast bacillus (AFB) smear as the initial diagnostic test. Our objective was to assess the yield and cost of a more intensive tuberculosis screening in HIV-infected patients starting antiretroviral therapy (ART) in Durban, South Africa.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research